Annovis Bio, Inc.

Historical 13F Holders

Symbol
ANVS
CUSIP
03615A108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 03615A108 since 12/18/2024, largest first.

Filer % of Class Filed
Highbridge Capital Management, LLC 13G 6.1% 8/14/2026
Event 6/30/2026
Empery Asset Management, LP 13G
5.6% 7/29/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
CVI Investments, Inc. 13G/A
4.9% 5/12/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 59.4 k $75.4 k
2026 Q2 69 10.9 M $20.2 M
2026 Q1 63 4.72 M $10.5 M
2025 Q4 60 4.24 M $14.7 M
2025 Q3 47 2.04 M $4.22 M
2025 Q2 48 1.81 M $3.93 M
2025 Q1 50 2.09 M $3.13 M
2024 Q4 46 1.58 M $7.93 M
2024 Q3 45 1.18 M $9.53 M
2024 Q2 53 990 k $5.70 M
2024 Q1 54 1.23 M $14.5 M
2023 Q4 47 1.21 M $22.6 M
2023 Q3 31 1.11 M $10.5 M
2023 Q2 29 1.28 M $18.3 M
2023 Q1 24 752 k $11.6 M
2022 Q4 25 758 k $10.2 M
2022 Q3 26 738 k $10.0 M
2022 Q2 27 770 k $8.74 M
2022 Q1 26 901 k $12.0 M
2021 Q4 33 1.12 M $19.6 M
2021 Q3 39 1.14 M $36.2 M
2021 Q2 58 1.27 M $109 M
2021 Q1 32 834 k $23.1 M
2020 Q4 14 760 k $5.73 M
2020 Q3 13 316 k $1.52 M
2020 Q2 9 244 k $1.06 M
2020 Q1 9 193 k $582 k